North America Clot Busting Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Product, By Route of Administration, By Indication, By Country and Growth Forecast, 2023

List of Tables

The North America Clot Busting Drugs Market would witness market growth of 6.6% CAGR during the forecast period (2023-2030).

Thrombolytic drugs, commonly called clot-busting pharmaceuticals, are prescribed to treat particular medical conditions by dissolving blood clots. These drugs offer many benefits in the treatment of specific disorders. Blood clots can be promptly removed with the help of clot-busting drugs, especially when they are present suddenly, like ischemic strokes or myocardial infarctions (heart attacks). They work by triggering the body's clot-dissolving mechanism, aiding in blood flow recovery to the injured organ.

In rare cases, clot-busting drugs may be utilized instead of surgery. For instance, thrombolytic therapy can help dissolve the clot and clear the obstruction in pulmonary embolism when a blood clot stops the blood vessels in the lungs. This might eliminate the need for more invasive procedures like surgical embolectomy. The market is expected to increase more rapidly in the coming years due to all these factors.

Careful and controlled dosing is necessary to prevent excessive bleeding from wounds or cuts, allergic responses brought on by clot busters, low blood pressure, unusual bleeding in the urine or stools, and other drug side effects. Rarely are alternatives to clot-busting drugs available for the treatment of blood clots. Anticoagulant medications (like heparin or direct oral anticoagulants) may be the primary treatment in some cases of deep vein thrombosis or pulmonary embolism.

Heart disease is the primary cause of death in the United States, and stroke is the fifth leading cause. Cardiovascular health is improved as part of the Healthy People 2030 initiative, which focuses on preventing and treating heart disease and stroke. The second greatest cause of death in Canada is heart disease. According to data from the Canadian Chronic Disease Surveillance System (CCDSS) for 2017-2018, approximately 1 in 12 (or 2.6 million) Canadian individuals aged 20 and over encountered heart disease, and every hour, 14 Canadian adults age 20 and over with heart disease die. As a result of this high prevalence of such conditions, the market is estimated to grow.

The US market dominated the North America Clot Busting Drugs Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $11.7 billion by 2030. The Canada market is estimated to witness a CAGR of 9% during (2023 - 2030). Additionally, The Mexico market would showcase a CAGR of 8.1% during (2023 - 2030).

Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy and Online Pharmacy. Based on Product, the market is segmented into Anticoagulants, Thrombolytic Drugs, Anti-Platelet Drugs and Others. Based on Route of Administration, the market is segmented into Injectable and Oral. Based on Indication, the market is segmented into Pulmonary Embolism, Atrial Fibrillation, Deep Vein Thrombosis and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sanofi S.A., Dr. Reddy's Laboratories Ltd., Bayer AG, Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Ltd., Bristol Myers Squibb Company, Eli Lilly And Company, Johnson & Johnson (Johnson & Johnson Services, Inc.), Pfizer, Inc., and Merck & Co., Inc.

Scope of the Study

Market Segments covered in the Report:

By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

By Product

Anticoagulants
Thrombolytic Drugs
Anti-Platelet Drugs
Others

By Route of Administration

Injectable
Oral

By Indication

Pulmonary Embolism
Atrial Fibrillation
Deep Vein Thrombosis
Others

By Country

US
Canada
Mexico
Rest of North America

Companies Profiled

Sanofi S.A.
Dr. Reddy's Laboratories Ltd.
Bayer AG
Boehringer Ingelheim International GmbH
Sun Pharmaceutical Industries Ltd.
Bristol Myers Squibb Company
Eli Lilly And Company
Johnson & Johnson (Johnson & Johnson Services, Inc.)
Pfizer, Inc.
Merck & Co., Inc.

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 North America Clot Busting Drugs Market, by Distribution Channel
- 1.4.2 North America Clot Busting Drugs Market, by Product
- 1.4.3 North America Clot Busting Drugs Market, by Route of Administration
- 1.4.4 North America Clot Busting Drugs Market, by Indication
- 1.4.5 North America Clot Busting Drugs Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
3.3 Porter's Five Forces Analysis

Chapter 4. North America Clot Busting Drugs Market by Distribution Channel

4.1 North America Hospital Pharmacy Market by Country
4.2 North America Retail Pharmacy Market by Country
4.3 North America Online Pharmacy Market by Country

Chapter 5. North America Clot Busting Drugs Market by Product

5.1 North America Anticoagulants Market by Country
5.2 North America Thrombolytic Drugs Market by Country
5.3 North America Anti-Platelet Drugs Market by Country
5.4 North America Others Market by Country

Chapter 6. North America Clot Busting Drugs Market by Route of Administration

6.1 North America Injectable Market by Country
6.2 North America Oral Market by Country

Chapter 7. North America Clot Busting Drugs Market by Indication

7.1 North America Pulmonary Embolism Market by Country
7.2 North America Atrial Fibrillation Market by Country
7.3 North America Deep Vein Thrombosis Market by Country
7.4 North America Others Market by Country

Chapter 8. North America Clot Busting Drugs Market by Country

8.1 US Clot Busting Drugs Market
- 8.1.1 US Clot Busting Drugs Market by Distribution Channel
- 8.1.2 US Clot Busting Drugs Market by Product
- 8.1.3 US Clot Busting Drugs Market by Route of Administration
- 8.1.4 US Clot Busting Drugs Market by Indication
8.2 Canada Clot Busting Drugs Market
- 8.2.1 Canada Clot Busting Drugs Market by Distribution Channel
- 8.2.2 Canada Clot Busting Drugs Market by Product
- 8.2.3 Canada Clot Busting Drugs Market by Route of Administration
- 8.2.4 Canada Clot Busting Drugs Market by Indication
8.3 Mexico Clot Busting Drugs Market
- 8.3.1 Mexico Clot Busting Drugs Market by Distribution Channel
- 8.3.2 Mexico Clot Busting Drugs Market by Product
- 8.3.3 Mexico Clot Busting Drugs Market by Route of Administration
- 8.3.4 Mexico Clot Busting Drugs Market by Indication
8.4 Rest of North America Clot Busting Drugs Market
- 8.4.1 Rest of North America Clot Busting Drugs Market by Distribution Channel
- 8.4.2 Rest of North America Clot Busting Drugs Market by Product
- 8.4.3 Rest of North America Clot Busting Drugs Market by Route of Administration
- 8.4.4 Rest of North America Clot Busting Drugs Market by Indication

Chapter 9. Company Profiles

9.1 Sanofi S.A.
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Segmental and Regional Analysis
- 9.1.4 Research & Development Expense
- 9.1.5 Recent strategies and developments:
  - 9.1.5.1 Trials and Approvals:
- 9.1.6 SWOT Analysis
9.2 Dr. Reddy's Laboratories Ltd.
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Research & Development Expense
- 9.2.5 SWOT Analysis
9.3 Bayer AG
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Research & Development Expense
- 9.3.5 SWOT Analysis
9.4 Boehringer Ingelheim International Gmbh
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Regional & Segmental Analysis
- 9.4.4 Research & Development Expenses
- 9.4.5 Recent strategies and developments:
  - 9.4.5.1 Partnerships, Collaborations, and Agreements:
- 9.4.6 SWOT Analysis
9.5 Sun Pharmaceutical Industries Ltd.
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Regional Analysis
- 9.5.4 Research & Development Expenses
- 9.5.5 SWOT Analysis
9.6 Bristol Myers Squibb Company
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Regional Analysis
- 9.6.4 Research & Development Expenses
- 9.6.5 Recent strategies and developments:
  - 9.6.5.1 Partnerships, Collaborations, and Agreements:
- 9.6.6 SWOT Analysis
9.7 Eli Lilly And Company
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Regional Analysis
- 9.7.4 Research & Development Expenses
- 9.7.5 SWOT Analysis
9.8 Johnson & Johnson (Johnson & Johnson Services, Inc.)
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Segmental &Regional Analysis
- 9.8.4 Research & Development Expenses
- 9.8.5 SWOT Analysis
9.9 Pfizer, Inc.
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 SWOT Analysis
- 9.9.4 Regional & Segmental Analysis
- 9.9.5 Research & Development Expense
- 9.9.6 SWOT Analysis
9.10. Merck & Co., Inc.
- 9.10.1 Company Overview
- 9.10.2 Financial Analysis
- 9.10.3 Segmental and Regional Analysis
- 9.10.4 Research & Development Expenses
- 9.10.5 SWOT Analysis

LIST OF TABLES

TABLE 1 North America Clot Busting Drugs Market, 2019 - 2022, USD Million
TABLE 2 North America Clot Busting Drugs Market, 2023 - 2030, USD Million
TABLE 3 North America Clot Busting Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 4 North America Clot Busting Drugs Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 5 North America Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 6 North America Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 7 North America Retail Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 8 North America Retail Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 9 North America Online Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 10 North America Online Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 11 North America Clot Busting Drugs Market by Product, 2019 - 2022, USD Million
TABLE 12 North America Clot Busting Drugs Market by Product, 2023 - 2030, USD Million
TABLE 13 North America Anticoagulants Market by Country, 2019 - 2022, USD Million
TABLE 14 North America Anticoagulants Market by Country, 2023 - 2030, USD Million
TABLE 15 North America Thrombolytic Drugs Market by Country, 2019 - 2022, USD Million
TABLE 16 North America Thrombolytic Drugs Market by Country, 2023 - 2030, USD Million
TABLE 17 North America Anti-Platelet Drugs Market by Country, 2019 - 2022, USD Million
TABLE 18 North America Anti-Platelet Drugs Market by Country, 2023 - 2030, USD Million
TABLE 19 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 20 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 21 North America Clot Busting Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 22 North America Clot Busting Drugs Market by Route of Administration, 2023 - 2030, USD Million
TABLE 23 North America Injectable Market by Country, 2019 - 2022, USD Million
TABLE 24 North America Injectable Market by Country, 2023 - 2030, USD Million
TABLE 25 North America Oral Market by Country, 2019 - 2022, USD Million
TABLE 26 North America Oral Market by Country, 2023 - 2030, USD Million
TABLE 27 North America Clot Busting Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 28 North America Clot Busting Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 29 North America Pulmonary Embolism Market by Country, 2019 - 2022, USD Million
TABLE 30 North America Pulmonary Embolism Market by Country, 2023 - 2030, USD Million
TABLE 31 North America Atrial Fibrillation Market by Country, 2019 - 2022, USD Million
TABLE 32 North America Atrial Fibrillation Market by Country, 2023 - 2030, USD Million
TABLE 33 North America Deep Vein Thrombosis Market by Country, 2019 - 2022, USD Million
TABLE 34 North America Deep Vein Thrombosis Market by Country, 2023 - 2030, USD Million
TABLE 35 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 36 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 37 North America Clot Busting Drugs Market by Country, 2019 - 2022, USD Million
TABLE 38 North America Clot Busting Drugs Market by Country, 2023 - 2030, USD Million
TABLE 39 US Clot Busting Drugs Market, 2019 - 2022, USD Million
TABLE 40 US Clot Busting Drugs Market, 2023 - 2030, USD Million
TABLE 41 US Clot Busting Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 42 US Clot Busting Drugs Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 43 US Clot Busting Drugs Market by Product, 2019 - 2022, USD Million
TABLE 44 US Clot Busting Drugs Market by Product, 2023 - 2030, USD Million
TABLE 45 US Clot Busting Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 46 US Clot Busting Drugs Market by Route of Administration, 2023 - 2030, USD Million
TABLE 47 US Clot Busting Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 48 US Clot Busting Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 49 Canada Clot Busting Drugs Market, 2019 - 2022, USD Million
TABLE 50 Canada Clot Busting Drugs Market, 2023 - 2030, USD Million
TABLE 51 Canada Clot Busting Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 52 Canada Clot Busting Drugs Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 53 Canada Clot Busting Drugs Market by Product, 2019 - 2022, USD Million
TABLE 54 Canada Clot Busting Drugs Market by Product, 2023 - 2030, USD Million
TABLE 55 Canada Clot Busting Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 56 Canada Clot Busting Drugs Market by Route of Administration, 2023 - 2030, USD Million
TABLE 57 Canada Clot Busting Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 58 Canada Clot Busting Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 59 Mexico Clot Busting Drugs Market, 2019 - 2022, USD Million
TABLE 60 Mexico Clot Busting Drugs Market, 2023 - 2030, USD Million
TABLE 61 Mexico Clot Busting Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 62 Mexico Clot Busting Drugs Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 63 Mexico Clot Busting Drugs Market by Product, 2019 - 2022, USD Million
TABLE 64 Mexico Clot Busting Drugs Market by Product, 2023 - 2030, USD Million
TABLE 65 Mexico Clot Busting Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 66 Mexico Clot Busting Drugs Market by Route of Administration, 2023 - 2030, USD Million
TABLE 67 Mexico Clot Busting Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 68 Mexico Clot Busting Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 69 Rest of North America Clot Busting Drugs Market, 2019 - 2022, USD Million
TABLE 70 Rest of North America Clot Busting Drugs Market, 2023 - 2030, USD Million
TABLE 71 Rest of North America Clot Busting Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 72 Rest of North America Clot Busting Drugs Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 73 Rest of North America Clot Busting Drugs Market by Product, 2019 - 2022, USD Million
TABLE 74 Rest of North America Clot Busting Drugs Market by Product, 2023 - 2030, USD Million
TABLE 75 Rest of North America Clot Busting Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 76 Rest of North America Clot Busting Drugs Market by Route of Administration, 2023 - 2030, USD Million
TABLE 77 Rest of North America Clot Busting Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 78 Rest of North America Clot Busting Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 79 Key Information - Sanofi S.A.
TABLE 80 Key Information - Dr. Reddy's Laboratories Ltd.
TABLE 81 Key Information - Bayer AG
TABLE 82 Key Information - Boehringer Ingelheim International GmbH
TABLE 83 Key Information - Sun Pharmaceutical Industries Ltd.
TABLE 84 Key Information - Bristol Myers Squibb Company
TABLE 85 Key Information - Eli Lilly And Company
TABLE 86 Key Information - Johnson & Johnson
TABLE 87 Key Information - Pfizer, Inc.
TABLE 88 Key Information - Merck & Co., Inc.

List of Figures

FIG 1 Methodology for the research
FIG 2 North America Clot Busting Drugs Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Clot Busting Drugs Market
FIG 4 Porter's Five Forces Analysis - Clot Busting Drugs Market
FIG 5 North America Clot Busting Drugs Market share by Distribution Channel, 2022
FIG 6 North America Clot Busting Drugs Market share by Distribution Channel, 2030
FIG 7 North America Clot Busting Drugs Market by Distribution Channel, 2019 - 2030, USD Million
FIG 8 North America Clot Busting Drugs Market share by Product, 2022
FIG 9 North America Clot Busting Drugs Market share by Product, 2030
FIG 10 North America Clot Busting Drugs Market by Product, 2019 - 2030, USD Million
FIG 11 North America Clot Busting Drugs Market share by Route of Administration, 2022
FIG 12 North America Clot Busting Drugs Market share by Route of Administration, 2030
FIG 13 North America Clot Busting Drugs Market by Route of Administration, 2019 - 2030, USD Million
FIG 14 North America Clot Busting Drugs Market share by Indication, 2022
FIG 15 North America Clot Busting Drugs Market share by Indication, 2030
FIG 16 North America Clot Busting Drugs Market by Indication, 2019 - 2030, USD Million
FIG 17 North America Clot Busting Drugs Market share by Country, 2022
FIG 18 North America Clot Busting Drugs Market share by Country, 2030
FIG 19 North America Clot Busting Drugs Market by Country, 2019 - 2030, USD Million
FIG 20 Swot Analysis: Sanofi S.A.
FIG 21 Swot Analysis: Dr. Reddy's Laboratories Ltd.
FIG 22 Swot Analysis: Bayer AG
FIG 23 Swot Analysis: Boehringer Ingelheim International GmbH
FIG 24 SWOT Analysis: Sun Pharmaceutical Industries Ltd.
FIG 25 SWOT Analysis: Bristol Myers Squibb Company
FIG 26 Swot Analysis: Eli Lilly And Company
FIG 27 Swot Analysis: Johnson & Johnson
FIG 28 Swot Analysis: Pfizer, Inc.
FIG 29 Swot Analysis: Pfizer, Inc.
FIG 30 Swot Analysis: Merck & Co., Inc.

North America Clot Busting Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Product, By Route of Administration, By Indication, By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents